<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00624572</url>
  </required_header>
  <id_info>
    <org_study_id>CHX0784</org_study_id>
    <nct_id>NCT00624572</nct_id>
  </id_info>
  <brief_title>Efficacy of Chlorexidine as Intracanal Medicament in Primary Teeth</brief_title>
  <official_title>Efficacy of 1% Chlorexidine Gel as Intracanal Medicament in Primary Molar Teeth - a Clinical and Microbiological Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidade Federal do Ceara</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidade Federal do Ceara</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the action of the chlorexidine as intracanal&#xD;
      medicament in the reduction of the levels of bacteria inside root canals of primary molar&#xD;
      teeth with pulpal necrosis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>October 2007</start_date>
  <completion_date type="Anticipated">February 2009</completion_date>
  <primary_completion_date type="Anticipated">November 2008</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Dental Pulp Necrosis</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>chlorexidine</intervention_name>
    <description>Chlorexidine gel 1% during 7 days inside root canals</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy children of both gender;&#xD;
&#xD;
          -  Without history of reactions or alergical diseases;&#xD;
&#xD;
          -  With situated age between 04 and 08 years of age&#xD;
&#xD;
          -  With normal standard of growth and development&#xD;
&#xD;
          -  Patients with necessity of radical endodontic treatment (pulpectomy) in, at least, two&#xD;
             primary molar teeth in different hemi-arches.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with history of alergical diseases&#xD;
&#xD;
          -  Patients with allergy to any type of medicine and/or foods&#xD;
&#xD;
          -  Patients with comprometimento of its general state of health&#xD;
&#xD;
          -  Healthy patients with risk to develop bacterial endocardite or patients that their&#xD;
             general state of health can be aggravated had the transitory bacteremies, as for&#xD;
             example children with congenital cardiac illnesses&#xD;
&#xD;
          -  Patients who are making use of sistemis antibiotics, or that they have made use of&#xD;
             sistemic antibiotic in the period of 3 (three) months before the beginning of the&#xD;
             endodontic treatment&#xD;
&#xD;
          -  With periapical x-ray evidencing less than 2/3 of remaining root of the primary tooth&#xD;
             to be treated&#xD;
&#xD;
          -  Patients whose tooth with endodontic necessity to meet in advanced state of root&#xD;
             pathological reabsortion&#xD;
&#xD;
          -  Patients whose legal responsible or parents to refuse to sign the term of free and&#xD;
             clarified assent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>8 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ramille Araújo Lima</name>
      <address>
        <city>Fortaleza</city>
        <state>Ceará</state>
        <zip>60440-810</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>February 2008</verification_date>
  <study_first_submitted>February 15, 2008</study_first_submitted>
  <study_first_submitted_qc>February 25, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 27, 2008</study_first_posted>
  <last_update_submitted>February 25, 2008</last_update_submitted>
  <last_update_submitted_qc>February 25, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 27, 2008</last_update_posted>
  <responsible_party>
    <name_title>Ramille Araújo Lima</name_title>
    <organization>Federal University of Ceará</organization>
  </responsible_party>
  <keyword>primary teeth</keyword>
  <keyword>chlorexidine</keyword>
  <keyword>root canal therapy</keyword>
  <keyword>Pulpectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dental Pulp Necrosis</mesh_term>
    <mesh_term>Necrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

